Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-014354
Filing Date
2025-02-14
Accepted
2025-02-14 18:12:52
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 21333
2 EXHIBIT 99.1 tm256516d1_ex99-1.htm EX-99.1 17722
  Complete submission text file 0001104659-25-014354.txt   40757
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Subject) CIK: 0001612940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88671 | Film No.: 25631600
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME
Business Address LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME 0031102411555
VAN HERK INVESTMENTS B.V. (Filed by) CIK: 0001633120 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A